Conroy AL, Datta D, John CC. What causes severe malaria and its complications in children? Lessons learned over the past 15 years. BMC Med. 2019;17(1):1–4.

Article  CAS  Google Scholar 

Aditya NP, Vathsala PG, Vieira V, Murthy RS, Souto EB. Advances in nanomedicines for malaria treatment. Adv Coll Interface Sci. 2013;201:1–7.

Article  Google Scholar 

Birkholtz LM, Bornman R, Focke W, Mutero C, De Jager C. Sustainable malaria control: transdisciplinary approaches for translational applications. Malar J. 2012;11:1–1.

Article  Google Scholar 

Takala-Harrison S, Laufer MK. Antimalarial drug resistance in Africa: key lessons for the future. Ann N Y Acad Sci. 2015;1342(1):62–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yan G, Li A, Zhang A, Sun Y, Liu J. Polymer-based nanocarriers for co-delivery and combination of diverse therapies against cancers. Nanomaterials. 2018;8(2):85.

Article  PubMed  PubMed Central  Google Scholar 

Whegang SY, Tahar R, Foumane VN, Soula G, Gwét H, Thalabard J, Basco LK. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malar J. 2010;9:56.

Article  PubMed  PubMed Central  Google Scholar 

Jarcho S. Malaria and murder (Joseph Jones, 1878). Bull N Y Acad Med. 1968;44(6):759.

PubMed  PubMed Central  CAS  Google Scholar 

Garnham PCC. Malaria in its various vertebrate hosts. In: Kreier JP, editor. Malaria. Part 1. Epidemiology, chemotherapy, morphology and metabolism. New York: Academic Press; 1980. p. 95–144.

Google Scholar 

https://www.cdc.gov/dpdx/malaria/index.html. Accessed on 25 July 2024

Moles E, Urbán P, Jiménez-Díaz MB, Viera-Morilla S, Angulo-Barturen I, Busquets MA, Fernàndez-Busquets X. Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy. J Control Release. 2015;210:217–29.

Article  PubMed  CAS  Google Scholar 

Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70.

Article  PubMed  Google Scholar 

Witika BA, Makoni PA, Matafwali SK, Chabalenge B, Mwila C, Kalungia AC, Nkanga CI, Bapolisi AM, Walker RB. Biocompatibility of biomaterials for nanoencapsulation: Current approaches. Nanomaterials. 2020;10(9):1649.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gutierrez RM, Mendez JV, Vazquez IA. A novel approach to the oral delivery of bio nanostructures for systemic disease. In: Nanostructures for Oral Medicine. Elsevier; 2017. pp. 27–59. https://doi.org/10.1016/B978-0-323-47720-8.00002-X.

White NJ. Antimalarial drug resistance. J Clin Investig. 2004;113(8):1084–92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gelband H, Panosian CB, Arrow KJ, editors. Saving lives, buying time: economics of malaria drugs in an age of resistance. https://doi.org/10.17226/11017.

Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol. 2006;4(9):682–95.

Article  PubMed  CAS  Google Scholar 

Murray CK, Gasser RA Jr, Magill AJ, Miller RS. Update on rapid diagnostic testing for malaria. Clin Microbiol Rev. 2008;21(1):97–110.

Article  PubMed  PubMed Central  Google Scholar 

Burrows JN, Burlot E, Campo B, Cherbuin S, Jeanneret S, Leroy D, Spangenberg T, Waterson D, Wells TN, Willis P. Antimalarial drug discovery–the path towards eradication. Parasitology. 2014;141(1):128–39.

Article  PubMed  Google Scholar 

Prasad M, Lambe UP, Brar B, Shah I, Manimegalai J, Ranjan K, Rao R, Kumar S, Mahant S, Khurana SK, Iqbal HM. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world. Biomed Pharmacother. 2018;97:1521–37.

Article  PubMed  CAS  Google Scholar 

Chaves JB, Portugal Tavares de Moraes B, Regina Ferrarini S, Noéda Fonseca F, Silva AR, Gonçalves-de-Albuquerque CF. Potential of nanoformulations in malaria treatment. Front Pharmacol. 2022;13:999300.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gachelin G, Garner P, Ferroni E, Tröhler U, Chalmers I. Evaluating Cinchona bark and quinine for treating and preventing malaria. J R Soc Med. 2017;110(1):31–40.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH. Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J. 2017;284(16):2569–78.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Krishna S, Bustamante L, Haynes RK, Staines HM. Artemisinins: their growing importance in medicine. Trends Pharmacol Sci. 2008;29(10):520–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hokkanen M. Quinine, malarial fevers and mobility: a biography of a ‘European fetish’, c. 1859–c. 1940. In: Medicine, mobility and the empire. Manchester University Press; 2017. pp. 186–217. https://doi.org/10.7765/MSI/9781526123893.07.

O’Neill PM, Barton VE, Ward SA. The molecular mechanism of action of artemisinin—the debate continues. Molecules. 2010;15(3):1705–21.

Article  PubMed  PubMed Central  Google Scholar 

Bridgford JL, Xie SC, Cobbold SA, Pasaje CF, Herrmann S, Yang T, Gillett DL, Dick LR, Ralph SA, Dogovski C, Spillman NJ. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun. 2018;9(1):3801.

Article  PubMed  PubMed Central  Google Scholar 

Meshnick SR. Artemisinin antimalarials: mechanisms of action and resistance. Med Trop (Mars). 1998;58(3 Suppl):13–7.

PubMed  CAS  Google Scholar 

Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol. 2009;625(1–3):220–33.

Article  PubMed  CAS  Google Scholar 

Aderibigbe BA. Design of drug delivery systems containing artemisinin and its derivatives. Molecules. 2017;22(2):323.

Article  PubMed  PubMed Central  Google Scholar 

Liu CX. Discovery and development of artemisinin and related compounds. Chin Herb Med. 2017;9(2):101–14.

Article  Google Scholar 

Camarda G, Jirawatcharadech P, Priestley RS, Saif A, March S, Wong MH, Leung S, Miller AB, Baker DA, Alano P, Paine MJ. Antimalarial activity of primaquine operates via a two-step biochemical relay. Nat Commun. 2019;10(1):3226.

Article  PubMed  PubMed Central  Google Scholar 

Avula B, Tekwani BL, Chaurasiya ND, Fasinu P, Dhammika Nanayakkara NP, Bhandara Herath HM, Wang YH, Bae JY, Khan SI, Elsohly MA, McChesney JD. Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. Malar J. 2018;17:1–4.

Article  Google Scholar 

Sharma J, Gautam CS, Singh H, Singh J. Tafenoquine for Plasmodium vivax malaria: concerns regarding efficacy & safety. Indian J Med Res. 2021;154(6):797–805.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hyde JE. Drug-resistant malaria− an insight. FEBS J. 2007;274(18):4688–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Francosco GU. The introduction of cinchona in the treatment of malaria. J Trop Med Hyg. 1977;80(6):112–8.

Google Scholar 

Marcsisin SR, Reichard G, Pybus BS. Primaquine pharmacology in the context of CYP 2D6 pharmacogenomics: current state of the art. Pharmacol Ther. 2016;161:1.

Article